Tratamiento con oxigenación hiperbárica en oncología

Elías López; Delfina Romero-Feris

doi:10.56969/oc.v24i3.37

Autores/as

Elías López Servicio de Oncología, Hospital La Milagrosa, Madrid
Delfina Romero-Feris BioBarica

DOI:

https://doi.org/10.56969/oc.v24i3.37

Palabras clave:

oxigenación hiperbárica, oncología, radiolesiones, hipoxia tumoral, hyperbaric oxygen therapy, oncology, radioinduced injuries, tumoral hypoxia

Resumen

La terapia de oxigenación hiperbárica (TOHB) combate la hipoxia, factor predisponente para la resistencia a terapias oncológicas convencionales. Su uso como sensibilizador en terapias convencionales ha demostrado aumentar la efectividad de la radioterapia y disminuir la mortalidad en algunos tumores de cabeza y cuello y existe amplia evidencia de su uso en las lesiones radioinducidas. Más aún, en el tratamiento del dolor y bienestar general produce una mejora significativa en la calidad de vida del paciente oncológico. Se presentan 7 casos en los cuales la TOHB a 1.45 ATA fue eficaz en el tratamiento de radionecrosis, heridas, oncodolor o bienestar general. Deben realizarse estudios adicionales para comprobar la incorporación del oxígeno hiperbárico dentro de la terapéutica del cáncer

Citas

Thienpont B, Steinbacher J, Zhao H, et al. Tumour hypoxia causes DNA hypermethylation by reducing TET activity. Nature 2016; 537:63-8. DOI: https://doi.org/10.1038/nature19081

Bennett MH, Feldmeier J, Smee R, Milross C. Hyperbaric oxygenation for tumour sensitisation to radiotherapy. Cochrane Database Syst Rev 2012; CD005007. DOI: https://doi.org/10.1002/14651858.CD005007.pub3

Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer: a review. Target Oncol 2012; 7:233-42. DOI: https://doi.org/10.1007/s11523-012-0233-x

Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P. Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 2005; 11:RA279-89.

Feldmeier J, Carl U, Hartmann K, Sminia P. Hyperbaric oxygen: does it promote growth or recurrence of malignancy? Undersea Hyperb Med 2003; 30:1-18.

Yttersian Sletta K, Tveitarås MK, Lu N, et al. Oxygen- dependent regulation of tumor growth and metastasis in human breast cancer xenografts. PLoS One 2017; 12:1-19. DOI: https://doi.org/10.1371/journal.pone.0183254

Raa A, Stansberg C, Steen VM, Bjerkvig R, Reed RK, Stuhr LE. Hyperoxia retards growth and induces apoptosis and loss of glands and blood vessels in DMBA-induced rat mammary tumors. BMC Cancer 2007; 30:7:23. DOI: https://doi.org/10.1186/1471-2407-7-23

Arıcıgil M, Dündar MA, Yücel A, et al. Anti-inflammatory effects of hyperbaric oxygen on irradiated laryngeal tissues. Braz J Otorhinolaryngol 2018; 84:206-11. DOI: https://doi.org/10.1016/j.bjorl.2017.02.001

Feldmeier J, Heimbach RD, Davolt DA, McDonough MJ, Stegman BJ, Scheffield PJ Hyperbaric oxygen in the treatment of delayed radiation injuries of the extremities. Undersea Hyperb Med 2000; 27:15-8.

Hampson NB, Holm JR, Wreford-Brown CE, Feldmeier J. Prospective assessment of outcomes in 411 patients treated with hyperbaric oxygen for chronic radiation tissue injury. Cancer 2012; 118: 3860-8. DOI: https://doi.org/10.1002/cncr.26637

Liu YD, Wang ZB, Han G, Jin L, Zhao P. Hyperbaric oxygen relieves neuropathic pain through aKT/Tsc2/mTOR pathway activity to induce autophagy. J Pain Res 2019; 12:443-51. DOI: https://doi.org/10.2147/JPR.S189353

Wei J, Meng L, Hou X, et al. Radiation-induced skin reactions: mechanism and treatment. Cancer Manag Res 2018; 11:167-77. DOI: https://doi.org/10.2147/CMAR.S188655

Lloret M, Rivero J, García L, et al. Feasibility of a programme of hyperbaric oxygen treatment for toxicity. First Spanish experience. Póster presentado en XX Congreso de la Sociedad Española de Oncología Radioterápica, 2019.

Rodríguez-Pla M, Conde A, Pérez-Calatayud MJ, et al. Oxygen therapy at 1.4 atmospheres in radiation-induced cistitis and proctitis, Póster presentado en XX Congreso de la Sociedad Europea de Oncología Radioterápica, 2019.